Total Payments
$5,697
2024 Payments
$2,131
Companies
26
Transactions
275
Medicare Patients
8,868
Medicare Billing
$730,254
Payment Breakdown by Category
Food & Beverage$5,586 (98.1%)
Education$110.26 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,586 | 273 | 98.1% |
| Education | $110.26 | 2 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,284 | 66 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $490.49 | 24 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $458.24 | 17 | $0 (2024) |
| Amgen Inc. | $407.05 | 17 | $0 (2024) |
| Incyte Corporation | $404.59 | 19 | $0 (2024) |
| Janssen Biotech, Inc. | $359.65 | 19 | $0 (2024) |
| PFIZER INC. | $299.17 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $285.33 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $258.15 | 12 | $0 (2024) |
| LEO Pharma Inc. | $206.34 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,131 | 106 | ABBVIE INC. ($481.47) |
| 2023 | $1,597 | 72 | ABBVIE INC. ($237.19) |
| 2022 | $1,048 | 51 | ABBVIE INC. ($275.92) |
| 2021 | $920.58 | 46 | AbbVie Inc. ($289.15) |
All Payment Transactions
275 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.96 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $28.80 | General |
| 11/15/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $32.58 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Immunology | ||||||
| 11/01/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Immunology | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,452 | 4,576 | $1.1M | $212,976 |
| 2022 | 19 | 1,968 | 3,407 | $565,382 | $154,237 |
| 2021 | 22 | 2,247 | 4,024 | $670,370 | $187,930 |
| 2020 | 20 | 2,201 | 3,752 | $622,273 | $175,112 |
Total Patients
8,868
Total Services
15,759
Medicare Billing
$730,254
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 359 | 585 | $229,697 | $47,320 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 400 | 588 | $166,830 | $33,325 | 20.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 312 | 399 | $134,475 | $25,663 | 19.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 232 | 310 | $115,915 | $23,800 | 20.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 59 | 74 | $74,152 | $16,703 | 22.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 289 | 391 | $84,649 | $12,446 | 14.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 79 | 102 | $54,266 | $11,659 | 21.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 113 | 196 | $32,886 | $7,623 | 23.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 221 | 1,446 | $32,693 | $7,174 | 21.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 54 | 68 | $54,575 | $6,695 | 12.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 90 | 101 | $17,932 | $3,641 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $20,215 | $3,423 | 16.9% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 12 | 12 | $12,742 | $2,838 | 22.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $12,053 | $2,500 | 20.7% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $8,770 | $1,817 | 20.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 18 | 18 | $7,462 | $1,775 | 23.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 32 | 49 | $9,011 | $1,525 | 16.9% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $10,289 | $1,263 | 12.3% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 12 | 13 | $5,176 | $1,145 | 22.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $2,645 | $488.34 | 18.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 40 | 93 | $289.80 | $77.10 | 26.6% |
| Q0112 | All potassium hydroxide (koh) preparations | Office | 2023 | 13 | 13 | $143.00 | $74.23 | 51.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 284 | 405 | $113,497 | $31,823 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 307 | 400 | $79,504 | $22,142 | 27.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 247 | 305 | $72,175 | $19,043 | 26.4% |
About Mitzi Bray, PA
Mitzi Bray, PA is a Physician Assistant healthcare provider based in Oceanside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1912266883.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mitzi Bray, PA has received a total of $5,697 in payments from pharmaceutical and medical device companies, with $2,131 received in 2024. These payments were reported across 275 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,586).
As a Medicare-enrolled provider, Bray has provided services to 8,868 Medicare beneficiaries, totaling 15,759 services with total Medicare billing of $730,254. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Oceanside, CA
- Active Since 05/11/2012
- Last Updated 05/11/2012
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1912266883
Products in Payments
- RINVOQ (Biological) $580.31
- SKYRIZI (Biological) $557.84
- Sotyktu (Drug) $458.24
- Otezla (Drug) $407.05
- ILUMYA (Biological) $330.56
- TREMFYA (Drug) $310.36
- OPZELURA (Drug) $309.60
- EUCRISA (Drug) $283.90
- DUPIXENT (Biological) $279.73
- LIBTAYO (Biological) $269.11
- ADBRY (Biological) $186.37
- HUMIRA (Biological) $123.97
- COSENTYX (Drug) $122.86
- COSENTYX (Biological) $121.79
- Winlevi (Drug) $112.83
- AMELUZ (Drug) $109.62
- Cimzia (Drug) $107.00
- SPEVIGO (Drug) $102.82
- TALTZ (Drug) $87.68
- Zoryve (Drug) $86.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Oceanside
Dennis Brodsky, Pa-C, PA-C
Physician Assistant — Payments: $7,762
Physician Assistant $7,762
Yasmin Anwar, Pa, PA
Physician Assistant — Payments: $6,752
Physician Assistant $6,752
Gary Peterson, Pa, PA
Physician Assistant — Payments: $6,440
Physician Assistant $6,440
Mrs. Amanda Mcconnell, Pa, PA
Physician Assistant — Payments: $5,276
Physician Assistant $5,276
Adara Mifsud, Pa-C, PA-C
Physician Assistant — Payments: $3,661
Physician Assistant $3,661
Mrs. Susan Upbin, P.a.- C, P.A.- C
Physician Assistant — Payments: $1,536
Physician Assistant $1,536